McEwen (MUX) EBITDA Margin (2012 - 2026)

McEwen has reported EBITDA Margin for 15 years, with the latest figure at 13.01% in Q2 2026.

• On a quarterly basis, EBITDA Margin rose 2023.0% year-over-year to 13.01% in Q2 2026; TTM through Jun 2026 was 25.2%, a 4046.0% increase from a year earlier, with the FY2025 full-year figure at 1.34%, up 3033.0% from the prior year.
• EBITDA Margin was 13.01% for Q2 2026 at McEwen, down from 55.7% in the prior quarter.
• The five-year high for EBITDA Margin was 55.7% in Q1 2026, with the low at 138.75% in Q4 2022.
• Average EBITDA Margin over 5 years is 45.55%, with a median of 48.35% recorded in 2024.
• The sharpest annual moves came in 2022 and 2024: EBITDA Margin sank 7436 bps in 2022, then soared 9568 bps in 2024.
• Over 5 years, EBITDA Margin stood at 138.75% in 2022, then surged by 42 bps to 80.74% in 2023, then jumped by 46 bps to 43.39% in 2024, then surged by 179 bps to 34.2% in 2025, then tumbled by 62 bps to 13.01% in 2026.
• The last three EBITDA Margin figures came in at 13.01% (Q2 2026), 55.7% (Q1 2026), and 34.2% (Q4 2025), per Business Quant data.